These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 331411

  • 1. [Changes in cell-mediated immunity in leprosy patients[].
    Fliess EL, Bachmann AE.
    Rev Asoc Argent Microbiol; 1977; 9(1):28-36. PubMed ID: 331411
    [No Abstract] [Full Text] [Related]

  • 2. [Study of cellular hypersensitivity in leprosy, using the lymphocyte migration inhibition test].
    Del rey Calero J, Calbo Torrecillas F.
    Rev Sanid Hig Publica (Madr); 1970 Dec; 44(12):1319-32. PubMed ID: 5525221
    [No Abstract] [Full Text] [Related]

  • 3. Disturbance of the blood T:B lymphocyte ratio in lepromatous leprosy. Clinical and immunologic correlations.
    Dwyer JM, Bullock WE, Fields JP.
    N Engl J Med; 1973 May 17; 288(20):1036-9. PubMed ID: 4540496
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
    Laal S, Mishra RS, Nath I.
    Int J Lepr Other Mycobact Dis; 1987 Sep 17; 55(3):481-93. PubMed ID: 2958570
    [Abstract] [Full Text] [Related]

  • 7. Immunologic responses in patients with lepromatous leprosy.
    Rea TH, Quismorio FP, Harding B, Nies KM, Di Saia PJ, Levan NE, Friou GJ.
    Arch Dermatol; 1976 Jun 17; 112(6):791-800. PubMed ID: 1085131
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Etiological factors in delayed-type hypersensitivity reactions in leprosy.
    Klenerman P.
    Int J Lepr Other Mycobact Dis; 1987 Dec 17; 55(4):702-12. PubMed ID: 3123582
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immune deficit in patients with lepromatous leprosy: its nature and relation to genetic factors, spectrum, and duration of the illness.
    Saha K, Agarwal SK.
    Int J Lepr Other Mycobact Dis; 1979 Mar 17; 47(1):1-6. PubMed ID: 571846
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence of cell-mediated immune contrasuppression in lepromatous leprosy: modulation of a putative T contrasuppressor cell-subset.
    González-Amaro R, Salazar-González JF, Baranda L, Abud-Mendoza C, Moncada B, García R, Alcocer-Varela J.
    Clin Exp Immunol; 1988 Mar 17; 71(3):399-404. PubMed ID: 3133142
    [Abstract] [Full Text] [Related]

  • 19. Attempts to convert lepromatous into tuberculoid-type leprosy with blood lymphocyte extracts from sensitized donors.
    Silva C, Lima AO, Andrade LM, Mattos O.
    Clin Exp Immunol; 1973 Sep 17; 15(1):87-92. PubMed ID: 4765722
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.